NCT05633524View on ClinicalTrials.gov

HRR as a Novel Biomarker in Sjögren's Syndrome

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

November 21, 2022

Study Completion Date

November 21, 2022

Conditions
Sjögren's Syndrome
Interventions
OTHER

blood sample analysis

All subjects went through a routine ocular examination, and the peripheral venous blood samples were collected and analyzed

Trial Locations (1)

Unknown

Tianjin Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Eye Hospital

OTHER

NCT05633524 - HRR as a Novel Biomarker in Sjögren's Syndrome | Biotech Hunter | Biotech Hunter